Surgical management of gastroesophageal reflux disease in obesity

Digestive Diseases and Sciences

Volumn 53, Issue 9, 2008, Pages 2318-2329

  Ikramuddin, Sayeed ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bariatric surgery; Gastric bypass; Gastroesophageal reflux disease; Obesity; Roux en Y

Indexed keywords

CALCIUM; CYANOCOBALAMIN; GLUCAGON LIKE PEPTIDE 1; IRON; PROTON PUMP INHIBITOR; VITAMIN D;

ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; BODY WEIGHT; CLINICAL FEATURE; COMORBIDITY; DIARRHEA; GASTROESOPHAGEAL REFLUX; HUMAN; INTERMETHOD COMPARISON; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH ACID; STOMACH EMPTYING; STOMACH FUNDOPLICATION; WEIGHT REDUCTION;

BARIATRIC SURGERY; BODY MASS INDEX; FUNDOPLICATION; GASTRIC BYPASS; GASTROESOPHAGEAL REFLUX; GASTROPLASTY; HUMANS; OBESITY;

EID: 50249120575     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0415-7     Document Type: Article

References (55)

1. PE Scherer 2006 Adipose tissue: from lipid storage compartment to endocrine organ Diabetes 55 1537 1545 10.2337/db06-0263
2. AS Greenberg MS Obin 2006 Obesity and the role of adipose tissue in inflammation and metabolism Am J Clin Nutr 83 461S 465S
3. D Housa J Housová Z Vernerová M Haluzík 2006 Adipocytokines and cancer Physiol Res 55 233 244
4. N Barak ED Ehrenpreis JR Harrison MD Sitrin 2002 Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations Obes Rev 3 9 15 10.1046/j.1467-789X.2002.00049.x
5. CD Mercer SF Wren LR DaCosta IT Beck 1987 Lower esophageal sphincter pressure and gastroesophageal pressure gradients in excessively obese patients J Med 18 135 146
6. SA Wajed CG Streets CG Bremner TR DeMeester 2001 Elevated body mass disrupts the barrier to gastroesophageal reflux Arch Surg 136 1014 1018 10.1001/archsurg.136.9.1014
7. Kahrilas PJ, Pandolfino JE (2002) Gastroesophageal reflux disease and its complications, including Barrett's metaplasia. In: Feldman M, Friedman LS, Sleisenger MH (eds) Gastrointestinal and liver disease: pathophysiology/ diagnosis/management, 7th edn. Saunders, Philadelphia, pp 599-622
8. KR DeVault DO Castell 2005 American College of Gastroenterology: updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease Am J Gastroenterol 100 190 200 10.1111/j.1572-0241.2005.41217.x
9. TR DeMeester KH Fuchs CS Ball M Albertucci TC Smyrk JN Marcus 1987 Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux Ann Surg 206 414 426 10.1097/00000658- 198710000-00003
10. N Vakil 2007 The role of surgery in gastro-oesophageal reflux disease Aliment Pharmacol Ther 25 1365 1372
11. SJ Spechler E Lee D Ahnen RK Goyal I Hirano F Ramirez 2001 Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial JAMA 285 2331 2338 10.1001/jama.285.18.2331
12. N Vakil R Kirby M Shaw 2003 Clinical effectiveness of laparoscopic fundoplication in a US community Am J Med 114 1 5 10.1016/S0002-9343(02)01390-6
13. JA Dominitz CA Dire KG Billingsley JA Todd-Stenberg 2006 Complications and antireflux medication use after antireflux surgery Clin Gastroenterol Hepatol 4 299 305 10.1016/j.cgh.2005.12.019
14. A Madan A Minocha 2006 Despite high satisfaction, majority of gastro-oesophageal reflux disease patients continue to use proton pump inhibitors after antireflux surgery Aliment Pharmacol Ther 23 601 605 10.1111/j.1365-2036.2006.02788.x
15. A Klaus RA Hinder KR DeVault SR Achem 2003 Bowel dysfunction after laparoscopic antireflux surgery: incidence, severity, and clinical course Am J Med 114 6 9 10.1016/S0002-9343(02)01301-3
16. L Lundell P Miettinen HE Myrvold JG Hatlebakk L Wallin A Malm 2007 Nordic GORD study group: seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis Br J Surg 94 198 203 10.1002/bjs.5492
17. S Mehta J Bennett D Mahon M Rhodes 2006 Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: seven-year follow-up J Gastrointest Surg 10 1312 1316 10.1016/j.gassur.2006.07.010
18. AR Perez AC Moncure DW Rattner 2001 Obesity adversely affects the outcome of antireflux operations Surg Endosc 15 986 989 10.1007/s004640000392
19. CB Morgenthal E Lin MD Shane JG Hunter CD Smith 2007 Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes Surg Endosc 21 1978 1984 10.1007/s00464-007-9490-7
20. McNatt SS, Smith CD, Hunter JG et al (2000) Morbid obesity does not predict a poor outcome after laparoscopic antireflux surgery. Gastroenterology 118(suppl):SSAT A1033. Abstract 2260
21. MJ D'Alessio D Arnaoutakis N Giarelli DV Villadolid AS Rosemurgy 2005 Obesity is not a contraindication to laparoscopic Nissen fundoplication J Gastrointest Surg 9 949 954 10.1016/j.gassur.2005.04.019
22. National Institutes of Health (1992) Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 55(suppl 2):6155-6195
23. H Buchwald Y Avidor E Braunwald MD Jensen W Pories K Fahrbach 2004 Bariatric surgery: a systematic review and meta-analysis JAMA 292 1724 1737 10.1001/jama.292.14.1724
24. BM Balsiger JL Poggio J Mai KA Kelly MG Sarr 2000 Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity J Gastrointest Surg 4 598 605 10.1016/S1091-255X(00)80108-0
25. Ikramuddin S, Kendrick ML, Kellogg TA, Sarr MG (2007) Open and laparoscopic Roux-en-Y gastric bypass: our techniques. J Gastrointest Surg 11:217-228. doi: 10.1007/s11605-006-0028-4
26. BE Schneider L Villegas GL Blackburn EC Mun JF Critchlow DB Jones 2003 Laparoscopic gastric bypass surgery: outcomes J Laparoendosc Adv Surg Tech A 13 247 255 10.1089/109264203322333575
27. WJ Pories MS Swanson KG MacDonald SB Long PG Morris BM Brown 1995 Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann Surg 222 339 350 10.1097/00000658-199509000- 00011
28. H Buchwald S Ikramuddin 2002 Laparoscopic adjustable gastric banding in bariatric surgery: an overview of the LAP-BAND: introduction Am J Surg 184 1S 3S 10.1016/S0002-9610(02)01171-6
29. PR Schauer S Ikramuddin W Gourash R Ramanathan J Luketich 2000 Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity Ann Surg 232 515 529 10.1097/00000658-200010000-00007
30. PR Schauer B Burguera S Ikramuddin D Cottam W Gourash G Hamad 2003 Effect of laparoscopic Roux-en Y bypass on type 2 diabetes mellitus Ann Surg 238 467 484
31. DE Cummings DS Weigle RS Frayo PA Breen MK Ma EP Dellinger 2002 Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery N Engl J Med 346 1623 1630 10.1056/NEJMoa012908
32. BA Whitson DB Leslie TA Kellogg MA Maddaus H Buchwald CJ Billington 2007 Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study J Surg Res 141 31 39 10.1016/j.jss.2007.02.022
33. SE Greenway FL Greenway 3rd S Klein 2002 Effects of obesity surgery on non-insulin-dependent diabetes mellitus Arch Surg 137 1109 1117 10.1001/archsurg.137.10.1109
34. GH Ballantyne 2006 Peptide YY(1-36) and peptide YY(3-36): part I. Distribution, release and actions Obes Surg 16 651 658 10.1381/ 096089206776944959
35. GH Ballantyne 2006 Peptide YY(1-36) and peptide YY(3-36): part II. Changes after gastrointestinal surgery and bariatric surgery Obes Surg 16 795 803 10.1381/096089206777346619
36. GH Ballantyne D Farkas S Laker A Wasielewski 2006 Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass Obes Surg 16 1189 1197 10.1381/096089206778392158
37. F Rubino J Marescaux 2004 Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease Ann Surg 239 1 11 10.1097/01.sla.0000102989.54824.fc
38. SG Mattar F Qureshi D Taylor PR Schauer 2006 Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass Surg Endosc 20 850 854 10.1007/s00464-006-0513-6
39. CD Smith SB Herkes KE Behrns VF Fairbanks KA Kelly MG Sarr 1993 Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity Ann Surg 218 91 96 10.1097/00000658-199307000-00014
40. WH Johnson AZ Fernanadez TM Farrell KG Macdonald JP Grant RL McMahon 2007 Surgical revision of loop ("mini") gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass Surg Obes Relat Dis 3 37 41 10.1016/j.soard.2006.09.012
41. SC Smith CB Edwards GN Goodman 1997 Symptomatic and clinical improvement in morbidly obese patients with gastroesophageal reflux disease following Roux-en-Y gastric bypass Obes Surg 7 479 484 10.1381/096089297765555205
42. KB Jones Jr 1998 Roux-en-Y gastric bypass: an effective antireflux procedure in the less than morbidly obese Obes Surg 8 35 38 10.1381/ 096089298765555024
43. EE Frezza S Ikramuddin W Gourash T Rakitt A Kingston J Luketich 2002 Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass Surg Endosc 16 1027 1031 10.1007/s00464-001-8313-5
44. JB Dixon PE O'Brien 1999 Gastroesophageal reflux in obesity: the effect of lap-band placement Obes Surg 9 527 531 10.1381/096089299765552602
45. EJ Patterson DG Davis Y Khajanchee LL Swanström 2003 Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn Surg Endosc 17 1561 1565 10.1007/s00464-002-8955-y
46. A Ryden JS Torgerson 2006 The Swedish obese subjects study-what has been accomplished to date? Surg Obes Relat Dis 2 549 560 10.1016/j.soard.2006.07.006
47. NV Christou JS Sampalis M Liberman D Look S Augur AP McLean 2004 Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients Ann Surg 240 416 423 10.1097/01.sla.0000137343.63376.19
48. L Sjöström K Narbro CD Sjöström K Karason B Larsson IH Wede 2007 Swedish obese subjects study: effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 357 741 752 10.1056/NEJMoa066254
49. TD Adams RE Gress SC Smith RC Halverson SC Simper WD Rosamond 2007 Long-term mortality after gastric bypass surgery N Engl J Med 357 753 761 10.1056/NEJMoa066603
50. S Horgan D Pohl D Bogetti T Eubanks C Pellegrini 1999 Failed antireflux surgery: what have we learned from reoperations? Arch Surg 134 809 815 10.1001/archsurg.134.8.809
51. NJ Soper D Dunnegan 1999 Anatomic fundoplication failure after laparoscopic antireflux surgery Ann Surg 229 669 676 10.1097/00000658-199905000- 00009
52. LJ Wilson W Ma BI Hirschowitz 1999 Association of obesity with hiatal hernia and esophagitis Am J Gastroenterol 94 2840 2844 10.1111/j.1572-0241.1999. 01426.x
53. JE Pandolfino HB El-Serag Q Zhang N Shah SK Ghosh PJ Kahrilas 2006 Obesity: a challenge to esophagogastric junction integrity Gastroenterology 130 639 649 10.1053/j.gastro.2005.12.016
54. JG Hunter CD Smith GD Branum JP Waring TL Trus M Cornwell 1999 Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision Ann Surg 230 595 604 10.1097/00000658-199910000-00015
55. TA Kellogg R Andrade M Maddaus B Slusarek H Buchwald S Ikramuddin 2007 Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass Surg Obes Relat Dis 3 52 57 10.1016/j.soard.2006.08.011